TriSalus Life Sciences, Inc.

NasdaqGM:TLSI Stock Report

Market Cap: US$123.5m

TriSalus Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TLSI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
17 Dec 24BuyUS$249,999Frankenius Equity ABCompany62,972US$3.97
10 Dec 24SellUS$110,700Arjun DesaiIndividual30,000US$3.69
22 Nov 24BuyUS$22,750Mats WahlstromIndividual5,000US$4.55
21 Nov 24BuyUS$47,057Mats WahlstromIndividual10,727US$4.44
05 Oct 24SellUS$1,394Bryan CoxIndividual314US$4.44
13 Sep 24BuyUS$75,359Mary SzelaIndividual14,815US$5.20
10 Sep 24BuyUS$24,850Mary SzelaIndividual5,000US$4.97
28 Aug 24SellUS$50George MartinIndividual9US$5.50

Insider Trading Volume

Insider Buying: TLSI insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of TLSI?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,972,2996.47%
Individual Insiders8,515,41927.9%
General Public8,763,49028.7%
Institutions11,241,92936.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.9%.

Top Shareholders

Top 25 shareholders own 69.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
20.4%
Frankenius Equity AB
6,230,748US$25.2m1.02%100.0%
5.89%
James Pallotta
1,795,461US$7.3m0%no data
5.07%
Unique Diamond Investments Limited
1,546,569US$6.3m0%no data
4.56%
Gene McGrevin
1,390,474US$5.6m0%no data
4.55%
Lombard International Assurance S.A., Asset Management Arm
1,387,588US$5.6m80.2%8.51%
4.49%
Hw Investment Partners, LLC
1,370,028US$5.5m0%no data
4.25%
Mats Wahlstrom
1,295,174US$5.2m3.26%no data
3.06%
David Matlin
931,903US$3.8m0%no data
2.11%
Wealthcare Advisory Partners LLC
643,740US$2.6m0%0.07%
1.88%
Christopher Dewey
573,690US$2.3m0%no data
1.72%
Sean Murphy
525,267US$2.1m0%no data
1.71%
Michael Stansky
521,539US$2.1m0%no data
1.69%
Kerry Hicks
514,589US$2.1m0%no data
1.4%
Duquesne Family Office LLC
426,921US$1.7m0%0.05%
1.36%
The Vanguard Group, Inc.
416,138US$1.7m0%no data
1.06%
The Kerry Raymond Hicks Dynasty Trust
322,737US$1.3m0%no data
0.86%
Mary Szela
263,004US$1.1m8.15%no data
0.81%
George Martin
247,176US$1.0m0%no data
0.81%
Arjun Desai
247,127US$1.0m-10.8%no data
0.66%
Geode Capital Management, LLC
200,427US$811.7k45.4%no data
0.34%
Eugene R. Mcgrevin Roth Contributory Ira
102,993US$417.1k0%no data
0.32%
Millennium Management LLC
97,888US$396.5k-20.4%no data
0.31%
James Alecxih
94,754US$383.8k0%no data
0.27%
Millennium Trust Company LLC, Asset Management Arm
81,845US$331.5k0%100.0%
0.22%
Bryan Cox
68,535US$277.6k1.06%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 08:48
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TriSalus Life Sciences, Inc. is covered by 7 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
William PlovanicCanaccord Genuity
Ross OsbornCantor Fitzgerald & Co.
Justin WalshJonesTrading Institutional Services, LLC